Authorization

Medicover : Year-end report January-December 2020

STOCKHOLM, Feb. 12, 2021 /PRNewswire/ -- Fourth quarterAAAAAAAAAAA

Revenue amounted to a?297.7m (a?229.7m), an increase of 29.6% with an organic growth of 26.6%.AAAAAAAAAAAA



Operating profit (EBIT) was a?29.9m (a?10.8m), representing an operating margin of 10.1% (4.7%).AAAAAAAAAAA



Net profit amounted to a?18.8m (a?6.6m), which represents a net profit margin of 6.3% (2.9%).AAAAAAAAAAA



EBITDA was a?53.1m (a?33.4m), an increase of 59.1%. EBITDA margin was 17.8% (14.5%).AAAAAAAAAAA



EBITDAaL amounted to a?41.2m (a?22.3m), corresponding to an EBITDAaL margin of 13.9% (9.7%).AAAAAAAAAAAA



Net cash flow from operating activities was a?40.4m (a?25.0m).AAAAAAAAAAA



Basic/diluted earnings per share were a?0.123 (a?0.048).AAAAAAAAAAAA



Covid-19 had a positive financial impact on operating performance.

Full yearAAAAAAAAAAA

Revenue amounted to a?997.8m (a?844.4m), an increase of 18.2% with an organic growth of 11.3%.AAAAAAAAAAAA



Operating profit (EBIT) was a?61.3m (a?46.5m), an increase of 32.1%, representing an operating margin of 6.1% (5.5%).AAAAAAAAAAA



Net profit amounted to a?27.3m (a?24.7m), which represents a net profit margin of 2.7% (2.9%).AAAAAAAAAAA



EBITDA was a?157.5m (a?120.7m), an increase of 30.6%. EBITDA margin was 15.8% (14.3%).AAAAAAAAAAA



EBITDAaL amounted to a?108.5m (a?80.6m), an increase of 34.7% corresponding to an EBITDAaL margin of 10.9% (9.5%).AAAAAAAAAAAA



Net cash flow from operating activities was a?156.0m (a?87.3m).AAAAAAAAAAA



Basic/diluted earnings per share were a?0.182 (a?0.168).AAAAAAAAAAAA



Directed share issue of 15 million shares completed in June 2020, net proceeds of a?141.9m.AAAAAAAAAAA



The board of directors proposes a dividend for 2020 of a?0.07 per share.

REVENUE AND EARNINGS

a? millions (a?m)
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«     2021    »
 12345
6789101112
13141516171819
20212223242526
2728293031